Purchase Order AG6538P170084
- Not listed
- The U.S. government awarded a $158,000 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for a Sequel System 8M Upgrade on June 10, 2019, with completion targeted for July 9, 2019. The contract was issued by a civilian federal agency (Southeast Area) with performance to take place in Menlo Park, California. Pacific Biosciences specializes in advanced DNA and RNA sequencing technologies, and this award reflects the company's role as a critical supplier of high-throughput,...
- The U.S. government awarded a $22,894 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for a DNA/Polymerase Binding Kit P6 V2 on May 5, 2017, with an ultimate completion date of June 4, 2017. The contract was funded by a civilian federal agency within the Southeast Area and performed in Menlo Park, California. No set-aside designation was applied to this award. Pacific Biosciences specializes in advanced DNA and RNA sequencing technologies, providing high-throughput,...
- The U.S. government awarded a $7,980 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for a Template Prep Kit on February 4, 2016, with completion required by February 10, 2016. The contract was funded by the Plains Area civilian agency and performed at the contractor's facility in Menlo Park, California. No set-aside designation was applied to this award. Pacific Biosciences is a biotechnology company specializing in advanced DNA and RNA sequencing technologies,...
- The U.S. government awarded a $367,500 firm fixed-price definitive contract to Pacific Biosciences of California, Inc. for the SEQUEL SYSTEM (911) on December 29, 2015, with a completion date of February 29, 2016. The award was made by a civilian federal agency (Plains Area) without a set-aside designation, and work was performed in Menlo Park, California. Pacific Biosciences, a biotechnology company specializing in advanced DNA and RNA sequencing technologies, delivered sequencing systems and...
- On November 7, 2016, the federal government awarded a purchase order to Pacific Biosciences of California, Inc. for DNA sequencing reagent 4.0 V2 with a ceiling value of $21,108.22. This firm fixed-price contract was awarded without a set-aside designation by a civilian agency within the Southeast Area and was scheduled for completion by December 7, 2016. The work was performed at the contractor's facility in Menlo Park, California. Pacific Biosciences specializes in advanced DNA and RNA...
- Pacific Biosciences of California, Inc. received a $8,438.01 firm fixed price purchase order from the Plains Area civilian federal agency for a Sequel Binding Kit (3557), a consumable component for the company's advanced DNA and RNA sequencing systems. The award was issued on April 25, 2016, with an ultimate completion date of the same day, and carries no set-aside designation. The place of performance is listed as Menlo Park, CA, the company's headquarters location. This purchase order...
- The U.S. Department of Agriculture's Agricultural Research Service Field Research Implementation and Information Delivery awarded a firm-fixed-price delivery order to Pacific Biosciences of California, Inc., a manufacturer of scientific equipment and supplies, to provide its proprietary Sequel IIe DNA/RNA sequencing systems, reagents, and associated consumables. The $612,000 award, which does not have a set-aside designation, has a performance period through May 16, 2023 and supports the...
- The U.S. government awarded a $11,805 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for DNA/Polymerase Binding Kits (models 3035, 3036, and 3048) on March 23, 2016. The contract was executed without set-aside designation and required completion by March 30, 2016. Work was performed at Pacific Biosciences' facility in Menlo Park, California, with funding provided through a civilian federal agency under the Plains Area designation. Pacific Biosciences is a...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- This $77,750 firm-fixed-price purchase order was awarded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) to Pacific Biosciences of California, Inc., a small business manufacturer of specialized scientific equipment and consumables. The contract provides Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing systems, along with associated reagents and supplies, to support genomic research initiatives across the Department of Defense and other federal agencies. The award...
The U.S. government awarded a purchase order valued at $8,650 to Pacific Biosciences of California, Inc. for a Sequel Sequencing Kit on February 16, 2017, with completion by February 17, 2017. The contract was awarded on a firm fixed price basis with no set-aside designation to a civilian federal agency identified as Plains Area. Performance was established at Pacific Biosciences' location in Menlo Park, California. This award represents a direct procurement of sequencing reagents and consumables from the company, which specializes in advanced DNA and RNA sequencing technologies that support genomic research across federal institutions. Pacific Biosciences has established itself as a critical supplier to multiple federal agencies including the USDA, FDA, NIH, CDC, and Department of Defense through the delivery of sequencing instruments, reagent kits, and associated services. The company maintains two significant Indefinite Delivery Indefinite Quantity contract vehicles that facilitate ongoing procurement of its sequencing technologies: a $13.5 million IDIQ with USDA Agricultural Research Service and a $1 million IDIQ with the FDA. This particular purchase order likely represents a task order or direct procurement under one of these broader framework agreements or a standalone acquisition, supporting the government's genomic research capabilities in areas ranging from agricultural genetics to infectious disease analysis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 2/16/17 |